Inhalable therapies like inhalers and nasal sprays rely on Water for Injection (WFI), but why is its purity so vital for respiratory health? Unlike oral medications, these treatments deliver substances directly to the lungs—a sensitive organ where even minor impurities can cause harm. WFI’s ultra-pure composition, free of pathogens, endotoxins, and organic contaminants, eliminates the risk of pneumonia, bronchitis, or severe respiratory infections. This is especially critical for patients with chronic lung conditions, whose compromised respiratory systems are more susceptible to irritation or infection from impure water. As a primary ingredient in respiratory medicines, WFI ensures consistency and efficacy, allowing the active components to work as intended without interference from contaminants. Without WFI, inhalable therapies could exacerbate existing conditions or create new health crises. Its role goes beyond formulation; it’s a safeguard for patients who depend on these treatments to breathe easier. For pharmaceutical manufacturers, using WFI in inhalables isn’t just a regulatory requirement—it’s a commitment to protecting the most vulnerable users.  Click here to know more.